Search research articles
Contact Us
Filters
Showing results (191-200 of 251) with videos related to
Page
of 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study
M Schuler, U Bruntsch, E Späth-Schwalbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M Schmidt, M E Scheulen, C Dittrich, et al.
Journal of Cutaneous Pathology
|
June 23, 2021
Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature
Andrew M Schuler, Emily H Smith, Kristine M Chaudet, et al.
Oncotarget
|
April 14, 2016
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Anuj Suri, Xiugui Sheng, Kevin M Schuler, et al.
Zeitschrift Fur Rheumatologie
|
April 24, 2008
[A view Down Under. Self-management initiatives and patient education in Australia]
M Schwarze, R Kirchhof, M Schuler, et al.
Journal of Medicinal Chemistry
|
May 1, 1984
Synthesis and central nervous system properties of 2-[(alkoxycarbonyl)amino]-4(5)-phenyl-2-imidazolines
K Weinhardt, C C Beard, C Dvorak, et al.
British Journal of Haematology
|
February 13, 2001
Interleukin 12 induces activation of fibrinolysis and coagulation in humans
J E Portielje, W H Kruit, A J Eerenberg, et al.
Schmerz (Berlin, Germany)
|
July 20, 2012
[Pain assessment in elderly nursing home residents: methods paper for the S3-guideline development]
E Sirsch, M Schuler, T Fischer, et al.
Cancer Immunology, Immunotherapy : CII
|
February 3, 2009
HLA ligand profiles of primary renal cell carcinoma maintained in metastases
Juliane Sarah Stickel, Andreas O Weinzierl, Nina Hillen, et al.
Health and Quality of Life Outcomes
|
June 27, 2018
Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools
H J Alma, C de Jong, D Jelusic, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 251) with videos related to
Sort By:
Page
of 26
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study
M Schuler, U Bruntsch, E Späth-Schwalbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M Schmidt, M E Scheulen, C Dittrich, et al.
Journal of Cutaneous Pathology
|
June 23, 2021
Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature
Andrew M Schuler, Emily H Smith, Kristine M Chaudet, et al.
Oncotarget
|
April 14, 2016
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Anuj Suri, Xiugui Sheng, Kevin M Schuler, et al.
Zeitschrift Fur Rheumatologie
|
April 24, 2008
[A view Down Under. Self-management initiatives and patient education in Australia]
M Schwarze, R Kirchhof, M Schuler, et al.
Journal of Medicinal Chemistry
|
May 1, 1984
Synthesis and central nervous system properties of 2-[(alkoxycarbonyl)amino]-4(5)-phenyl-2-imidazolines
K Weinhardt, C C Beard, C Dvorak, et al.
British Journal of Haematology
|
February 13, 2001
Interleukin 12 induces activation of fibrinolysis and coagulation in humans
J E Portielje, W H Kruit, A J Eerenberg, et al.
Schmerz (Berlin, Germany)
|
July 20, 2012
[Pain assessment in elderly nursing home residents: methods paper for the S3-guideline development]
E Sirsch, M Schuler, T Fischer, et al.
Cancer Immunology, Immunotherapy : CII
|
February 3, 2009
HLA ligand profiles of primary renal cell carcinoma maintained in metastases
Juliane Sarah Stickel, Andreas O Weinzierl, Nina Hillen, et al.
Health and Quality of Life Outcomes
|
June 27, 2018
Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools
H J Alma, C de Jong, D Jelusic, et al.
Page
of 26